Skip to main content
. 2020 Nov;8(21):1402. doi: 10.21037/atm-20-2420

Figure 4.

Figure 4

The OS rates of BCLC stage B and C HBV-related HCC patients using PSM comparative analyses of ALPPS with TACE. No statistical difference was observed in OS rates of HBV-related HCC patients between ALPPS and TACE (P=0.241). OS, overall survival; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; PSM, propensity score matching; ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; TACE, transarterial chemoembolization.